← Back to headlines
Pfizer Raises 2026 Guidance Despite COVID-19 Sales Decline
Pfizer has managed to raise its 2026 financial guidance, overcoming a tumble in sales related to its COVID-19 products.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Banks Pause Sales of Products Linked to Mark Walter Amid Investigations
53m ago
Rating Agencies Maintain Stable Outlooks for French and Portuguese Sovereign Debt
57m ago
Canada’s Economy Rebounds With 3.3% Growth in Second Quarter
1h ago
FDA Approves Takeda's Mimrylo for Blood Cancer Condition Polycythemia Vera
1h ago